Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1

Primary hyperparathyroidism associated with multiple endocrine neoplasia type I (hyperparathyroidism/multiple endocrine neoplasia type 1) differs in many aspects from sporadic hyperparathyroidism, which is the most frequently occurring form of hyperparathyroidism. Bone mineral density has frequently been studied in sporadic hyperparathyroidism but it has very rarely been examined in cases of hyperparathyroidism/multiple endocrine neoplasia type 1. Cortical bone mineral density in hyperparathyroidism/multiple endocrine neoplasia type 1 cases has only recently been examined, and early, severe and frequent bone mineral losses have been documented at this site. Early bone mineral losses are highly prevalent in the trabecular bone of patients with hyperparathyroidism/multiple endocrine neoplasia type 1. In summary, bone mineral disease in multiple endocrine neoplasia type 1-related hyperparathyroidism is an early, frequent and severe disturbance, occurring in both the cortical and trabecular bones. In addition, renal complications secondary to sporadic hyperparathyroidism are often studied, but very little work has been done on this issue in hyperparathyroidism/multiple endocrine neoplasia type 1. It has been recently verified that early, frequent, and severe renal lesions occur in patients with hyperparathyroidism/multiple endocrine neoplasia type 1, which may lead to increased morbidity and mortality. In this article we review the few available studies on bone mineral and renal disturbances in the setting of hyperparathyroidism/multiple endocrine neoplasia type 1. We performed a meta-analysis of the available data on bone mineral and renal disease in cases of multiple endocrine neoplasia type 1-related hyperparathyroidism

Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1

The bone mineral density increments in patients with sporadic primary hyperparathyroidism after parathyroidectomy have been studied by several investigators, but few have investigated this topic in primary hyperparathyroidism associated with multiple endocrine neoplasia type 1. Further, as far as we know, only two studies have consistently evaluated bone mineral density values after parathyroidectomy in cases of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1. Here we revised the impact of parathyroidectomy (particularly total parathyroidectomy followed by autologous parathyroid implant into the forearm) on bone mineral density values in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1. Significant increases in bone mineral density in the lumbar spine and femoral neck values were found, although no short-term (15 months) improvement in bone mineral density at the proximal third of the distal radius was observed. Additionally, short-term and medium-term calcium and parathyroid hormone values after parathyroidectomy in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 are discussed. In most cases, this surgical approach was able to restore normal calcium/parathyroid hormone levels and ultimately lead to discontinuation of calcium and calcitriol supplementation

Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1

Primary hyperparathyroidism associated with multiple endocrine neoplasia type I (hyperparathyroidism/multiple endocrine neoplasia type 1) differs in many aspects from sporadic hyperparathyroidism, which is the most frequently occurring form of hyperparathyroidism. Bone mineral density has frequently been studied in sporadic hyperparathyroidism but it has very rarely been examined in cases of hyperparathyroidism/multiple endocrine neoplasia type 1. Cortical bone mineral density in hyperparathyroidism/multiple endocrine neoplasia type 1 cases has only recently been examined, and early, severe and frequent bone mineral losses have been documented at this site. Early bone mineral losses are highly prevalent in the trabecular bone of patients with hyperparathyroidism/multiple endocrine neoplasia type 1. In summary, bone mineral disease in multiple endocrine neoplasia type 1related hyperparathyroidism is an early, frequent and severe disturbance, occurring in both the cortical and trabecular bones. In addition, renal complications secondary to sporadic hyperparathyroidism are often studied, but very little work has been done on this issue in hyperparathyroidism/multiple endocrine neoplasia type 1. It has been recently verified that early, frequent, and severe renal lesions occur in patients with hyperparathyroidism/multiple endocrine neoplasia type 1, which may lead to increased morbidity and mortality. In this article we review the few available studies on bone mineral and renal disturbances in the setting of hyperparathyroidism/multiple endocrine neoplasia type 1. We performed a meta-analysis of the available data on bone mineral and renal disease in cases of multiple endocrine neoplasia type 1-related hyperparathyroidism

CARACTERIZAÇÃO DO MODELO INFLAMATÓRIO DE CISTITE INDUZIDA POR CICLOFOSFAMIDA EM CAMUNDONGOS SWISS

A Cistite Hemorrágica é um problema de saúde importante no mundo causado pelo uso da oxazoforinas. Apesar dos tratamentos disponíveis, há uma incidência de 2 até 40% em pacientes tratados com Ciclofosfamida (CYP). O objetivo deste trabalho foi caracterizar um modelo experimental de cistite induzida por CYP em camundongos Swiss. Para isto, camundongos fêmeas foram distribuídos em 5 grupos com 7 animais, onde 4 grupos sofreram eutanásia após 0,5, 6, 12 e 24h da aplicação de 150mg/kg de CYP via intraperitoneal. O grupo controle recebeu salina tamponada pela mesma via. Foram avaliados o peso da bexiga e seu aspecto histopatológico, o hemograma, e a contagem celular de medula óssea e linfonodo ilíaco. Os resultados demonstraram que houve aumento significativo do peso da bexiga nos tempos de 6 e 12h. Houve aumento na infamação aguda nestes dois tempos. Após 24 horas houve diminuição da resposta inflamatória aguda e início da fibrose. O número de leucócitos foi menor em todos os tempos em relação ao controle. Da mesma forma, o número de células da medula óssea foi menor nos tempos de 6, 12 e 24h. Por outro lado, o número de células do linfonodo aumentou após 12 horas. Concluímos que houve aumento progressivo da inflamação até as 12h  e que após 24h já há um processo de resolução do quadro inflamatório. Sendo assim, sugerimos a utilização do tempo de 12h como padrão experimental por ser o de maior disponibilidade de parâmetros elevados para avaliação da inflamação.Descritores: Cistite. Ciclofosfamida. Camundongo. Modelo experimental.AbstractCharacterization of cyclophosphamide-induced cystitis inflammatory model in Swiss mice. The Hemorragic Cystitis (HC) is an important health problem over the world caused by oxazoforines. Despite the available treatments, still have an incidence of 2 to 40% of HC in patients following treatment with Cyclophosphamide (CYP). The aim of this work was characterize a model of CYP-induced cystitis  in Swiss mice. Female mice were divided  in 5 groups with 7 animals each, 4 groups were killed 0.5, 6, 12 and 24h after an injection of CYP (150mg/kg). The control group received phosphate buffered saline at the same way. In each time the bladders were collected, weighted and prepared to histopathology analyses. The complete blood count was evaluated. The cell number from lymph nodes and bone marrow was quantified. The results showed that bladder weight was increased at 6thand 12th hour pos cystitis induction. There was acute inflammation increased after 6 and 12h. After 24h there was an initial fibrosis. The leucocytes count was decreased in all times. The cells number was decreased at 6th,12th, and 24th hours in bone marrow and it was increased at 12th in lymph nodes. We concluded that there is an increase in inflammatory parameters until the 12th hour pos CYP injection which are decreased at 24th hour. We suggest using the time of 12h as the standard experimental time because of the biggest availability parameters for evaluating.Descriptors: Cyclophosphamide. Cystitis. Mice. Experimental model

Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection

Burden of pneumonia caused by Streptococcus pneumoniae remains high despite the availability of conjugate vaccines. Mucosal immunization targeting the lungs is an attractive alternative for the induction of local immune responses to improve protection against pneumonia. Our group had previously described the development of poly(glycerol adipate-co-ω-pentadecalactone) (PGA-co-PDL) polymeric nanoparticles (NPs) adsorbed with Pneumococcal surface protein A from clade 4 (PspA4Pro) within L-leucine microcarriers (nanocomposite microparticles-NCMPs) for mucosal delivery targeting the lungs (NP/NCMP PspA4Pro). NP/NCMP PspA4Pro was now used for immunization of mice. Inoculation of this formulation induced anti-PspA4Pro IgG antibodies in serum and lungs. Analysis of binding of serum IgG to intact bacteria showed efficient binding to bacteria expressing PspA from clades 3, 4 and 5 (family 2), but no binding to bacteria expressing PspA from clades 1 and 2 (family 1) was observed. Both mucosal immunization with NP/NCMP PspA4Pro and subcutaneous injection of the protein elicited partial protection against intranasal lethal pneumococcal challenge with a serotype 3 strain expressing PspA from clade 5 (PspA5). Although similar survival levels were observed for mucosal immunization with NP/NCMP PspA4Pro and subcutaneous immunization with purified protein, NP/NCMP PspA4Pro induced earlier control of the infection. Conversely, neither immunization with NP/NCMP PspA4Pro nor subcutaneous immunization with purified protein reduced bacterial burden in the lungs after challenge with a serotype 19F strain expressing PspA from clade 1 (PspA1). Mucosal immunization with NP/NCMP PspA4Pro targeting the lungs is thus able to induce local and systemic antibodies, conferring protection only against a strain expressing PspA from the homologous family 2

POTENCIAL ANTI-INFLAMATÓRIO DAS FOLHAS DE Chenopodium ambrosioides L. NO MODELO DE CISTITE HEMORRÁGICA EM CAMUNDONGOS

A cistite hemorrágica (CH) possui etiologia infecciosa, medicamentosa ou radioterápica. Consiste na presença de hematúria macroscópica secundária a sangramento vesical e uma das suas possíveis causas é o uso de ciclofosfamida (CYP). Várias alternativas farmacológicas têm sido investigadas para o tratamento da CH. Dentre as possibilidades, o potencial terapêutico de espécies vegetais tem sido avaliado. A espécie Chenopodium ambrosioides L. (Amaranthaceae), tem sido utilizado popularmente como anti-infamatório, efeito que  tem  sido comprovado cientifcamente. Assim, o objetivo deste estudo  foi investigar os efeitos do extrato bruto hidroalcoólico (EBH) de folhas secas de C. ambrosioides na CH induzida em camundongos pela ciclofosfamida. Camundongos fêmeas da linhagem Swiss receberam 150 mg/kg de CYP por via intraperitoneal para indução de CH. Em seguida, os animais foram tratados em dose única de acordo com protocolo estabelecido para cada grupo: soro fsiológico a 0,9% (grupo Controle); diclofenaco potássico (grupo Diclofenaco); EBH com dose única de 5 (grupo EBH5) ou 50mg/kg (grupo EBH50). Após 12 horas da indução da CH, o sangue dos animais foi retirado para realização do hemograma.  Os animais foram então sacrifcados e as bexigas retiradas, avaliadas macroscopicamente (hemorragia) e pesadas. Foram removidos, ainda, os órgãos linfóides a fm de realizar contagem de células do baço, medula óssea e linfonodos. Os resultados demonstraram que houve diminuição do peso das bexigas e da hemorragia nos grupos Diclofenaco e EBH5 quando comparados ao grupo controle. Houve um aumento das células da medula óssea, baço e linfonodo mesentérico em todos os animais tratados em relação ao controle. Em relação ao hemograma houve apenas aumentos pontuais no grupo EBH50. Em conclusão, o extrato bruto hidroalcoólico de folhas de C. ambrosioides na dose de 5mg/Kg apresentou efeito anti-infamatório e imunoestimulante, pois diminuiu o peso e a hemorragia da bexiga, e aumentou a produção e proliferação de células linfóides. Diante dos resultados desse estudo, bem como da evidência de ausência de toxicidade de outros trabalhos, podemos sugerir o tratamento com este extrato como alternativa terapêutica nos modelos de CH induzida por CYP em camundongos.Descritores: Anti-infamatório. Chenopodium ambrosioides. Ciclofosfamida. Cistite.AbstractHemorrhagic cystitis (HC) has infectious, drug or radiotherapy etiology. Consists in the presence of macroscopic hematuria secondary to bladder bleeding, and one of its possible causes is the use of cyclophosphamide (CYP). Several pharmacological alternatives have been investigated for the treatment of HC. Among the possibilities, the therapeutic potential of plant species have been reported. The species Chenopodium ambrosioides L. (Amaranthaceae) has been popularly used as an anti-infammatory efect that has been proven scientifcally. The objective of this study was to investigate the efects of crude hydroalcoholic extract of dried leaves of C. ambrosioides in HC cyclophosphamide induced in mice. Female mice of the Swiss strain received 150 mg / kg of CYP intraperitoneally to induce HC. Then the animals were treated with a single dose according to protocol established for each group: normal saline 0.9% (control group); diclofenac (diclofenac group); hydroalcoholic extract with a single dose of 5 (EBH5 group) or 50 mg / kg (EBH50 group). After 12 hours from the induction of HC, the bleeding was performed in the animal for the complete blood count. The animals were then sacrifced and had their bladders removed, as assessed macroscopically (bleeding) and weighed. The lymphoid organs were also removed in order to perform spleen, bone marrow and lymph nodes cell count. The results demonstrated that there was a decrease in the weight of bladders and bleeding in the diclofenac group and EBH5 when compared to the control group. There was an increase of cells in the bone marrow, spleen and lymph node in all treated animals as compared to control. In blood count there were only occasional increases in EBH50 group. In conclusion, the hydroalcoholic crude extract of Chenopodium ambrosioides leaves at a dose of 5 mg / kg showed anti-infammatory and immunostimulatory efect as decreased body weight and bleeding of the bladder, and increased production and proliferation of lymphoid cells. Given the results of this study, as well as evidence of absence of toxicity in other studies, we suggest treatment with this extract as an alternative therapy in models of CH-induced CYP in mice.Descriptors: Anti-infammatory. Chenopodium ambrosioides. Cyclophosphamide. Cystitis

Comparison of Three Commercially Available Dengue NS1 Antigen Capture Assays for Acute Diagnosis of Dengue in Brazil

Dengue is the one of the most prevalent arthropod-borne viral diseases in tropical regions of the world. Manifestations may vary from asymptomatic to potentially fatal complications. Laboratorial diagnosis is essential to diagnose dengue and differentiate it from other diseases. Dengue virus non-structural protein 1 (NS1) may be used as a marker of acute dengue virus infection. Our results, based in the comparison of three NS1 antigen capture assays available, have shown that this approach is reliable for the early diagnosis of dengue infections, especially in the first four days after the onset of the symptoms. A lower sensitivity was observed in DENV-3 cases. Serum positive by virus isolation were more often detected than those positive by RT-PCR by all three assays. Only the Platelia™ NS1 test showed a higher sensitivity in confirming primary infections than secondary ones. In conclusion, NS1 antigen capture commercial kits are useful for diagnosis of acute primary and secondary dengue infections and, in endemic countries where secondary infections are expected to occur, may be used in combination with MAC-ELISA to increase the overall sensitivity of both tests

Plant chemicals and the sexual behavior of male tephritid fruit flies

Plant compounds affect insects in many different ways. In addition to being a food source, plants also contain secondary metabolites that may have positive and negative impacts on insects. The influence of these compounds on sexual behavior, in particular, has been the focus of many recent studies. Here, we review the existing literature on the effects of plant compounds on the sexual behavior of tephritid fruit fly males. We put special focus on polyphagous species whose males congregate in leks, where females exert strong mate selection. We first summarize the main findings related to plant compounds that increase male signaling behavior and attraction of females and consequently increase mating frequency, a phenomenon that has been recorded mainly for species of Anastrepha and Ceratitis. In other tephritid species, males are attracted to phenylpropanoids produced by plants (such as methyl eugenol or raspberry ketone) that, upon encounter, are consumed and sequestered by males. These compounds, or metabolic derivatives, which normally have negligible nutritional value, are included in the pheromone and also confer advantages in a sexual context: enhanced female attraction and improved male mating success. These phenomena have been reported for several Bactrocera species as well as for Zeugodacus cucurbitae. Because many tephritid species are serious pests, the effect of plant compounds on male behavior has been explored for potential incorporation into control strategies such as the sterile insect technique (SIT). We conclude noting several factors, such as age and nutrition during larval and adult stage, that modulate the effect of plant compounds on male mating behavior as well as some prominent gaps that preclude a thorough understanding of the plant-mediated enhancement of male sexual performance and hence limit our ability to effectively utilize phytochemicals in pest control strategies.Instituto de GenéticaFil: Segura, Diego Fernando. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Genética. Laboratorio de Genética de Insectos de Importancia Económica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Belliard, Silvina A. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Genética. Laboratorio de Genética de Insectos de Importancia Económica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Vera, María Teresa. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Tucumán. Facultad de Agronomía y Zootecnia; ArgentinaFil: Bachmann, Guillermo Enrique. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Genética. Laboratorio de Genética de Insectos de Importancia Económica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Ruiz, María Josefina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Tucumán. Facultad de Agronomía y Zootecnia; ArgentinaFil: Jofre-Barud, Flavia. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria San Juan; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Fernández, Patricia. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria Delta del Paraná; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Lopez, M. Liza. Instituto Nacional de Tecnología Agropecuaria (INTA). Estación Experimental Agropecuaria San Juan; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Shelly, Todd E. United States Department of Agriculture. Animal and Plant Health Inspection Service; Estados Unido